Keyphrases
S6 Kinase 1 (S6K1)
100%
RPS6
100%
Endometrial Cancer
100%
X-linked
100%
Aberrant Methylation
100%
Ribosomal S6 Kinase 4 (RSK4)
100%
Methylation
46%
Primary Endometrial Cancer
15%
Endometrial Tissue
15%
Transcript Level
7%
Tumor
7%
Non-associated
7%
Effective Treatment
7%
Tumor Grade
7%
Tumor Suppressor Gene
7%
Novel Therapies
7%
Fold Increase
7%
Treatment Effect
7%
Tumorigenesis
7%
Treatment Outcome
7%
Hypermethylation
7%
Clinical Variables
7%
Epigenetic Silencing
7%
ERK Pathway
7%
Methylation Status
7%
Fibroblast Growth Factor Receptor 2 (FGFR2)
7%
Recurrent Endometrial Cancer
7%
Hypermethylated
7%
Endometrial Cancer Cell Line
7%
Endometrial Tumor
7%
Endometrial Cells
7%
5-azacytidine
7%
MEK-ERK Pathway
7%
Demethylating Agents
7%
Medicine and Dentistry
Cancer
100%
Methylation
100%
S6 Kinase
100%
Uterine Cancer
75%
Cell Line
25%
Neoplasm
12%
Carcinogenesis
12%
Tumor Suppressor Gene
12%
Tumor
12%
Cell Signaling Pathway
12%
Fibroblast Growth Factor Receptor 2
12%
Endometrium Tumor
12%
Endometrial Cancer Cell Line
12%
Azacitidine
12%
Treatment Outcome
12%
Effective Treatment
12%
Pharmacology, Toxicology and Pharmaceutical Science
S6 Kinase
100%
Endometrium Cancer
100%
Neoplasm
14%
Carcinogenesis
14%
Fibroblast Growth Factor Receptor 2
14%
Azacitidine
14%
Tumor Suppressor Protein
14%
Endometrium Tumor
14%